# Arbutus Biopharma Corp: Form 8-K, filed Sep 28, 2016

- Company: [Arbutus Biopharma Corp](/companies/abus.md) (CIK 1447028)
- Form: 8-K
- Filed: 2016-09-28
- Accepted by EDGAR: Sep 28, 2016, 13:53 ET
- Period: 2016-09-26
- Accession: 0000912282-16-000848
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1447028/000091228216000848/arbutus8k_092816.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1447028/000091228216000848/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1447028/000091228216000848/arbutus8k_092816.htm

Filed Sep 28, 2016.
Source: SEC EDGAR, the filing index for accession 0000912282-16-000848. Last ingested by Listed: Nov 12, 2026, 17:55 ET. No prices; not investment advice.
